DrugPatentWatch Database Preview
Lannett Co Inc Company Profile
What is the competitive landscape for LANNETT CO INC, and when can generic versions of LANNETT CO INC drugs launch?
There is one US patent protecting LANNETT CO INC drugs.
There are fifteen patent family members on LANNETT CO INC drugs in twelve countries and one hundred and five supplementary protection certificates in twelve countries.
Summary for Lannett Co Inc
| International Patents: | 15 |
| US Patents: | 1 |
| Tradenames: | 101 |
| Ingredients: | 93 |
| NDAs: | 130 |
| Drug Master File Entries: | 1 |
Drugs and US Patents for Lannett Co Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett Co Inc | ZAROXOLYN | metolazone | TABLET;ORAL | 017386-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Lannett Co Inc | METAPROTERENOL SULFATE | metaproterenol sulfate | SYRUP;ORAL | 073632-001 | Jul 22, 1992 | RX | No | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Lannett Co Inc | DIPYRIDAMOLE | dipyridamole | TABLET;ORAL | 040898-001 | Apr 23, 2008 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Lannett Co Inc | OMEPRAZOLE | omeprazole | CAPSULE, DELAYED REL PELLETS;ORAL | 075410-003 | Jan 23, 2009 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Lannett Co Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Lannett Co Inc | MYKROX | metolazone | TABLET;ORAL | 019532-001 | Oct 30, 1987 | 4,517,179 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for LANNETT CO INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Capsules | 10 mg, 20 mg and 30 mg | ➤ Subscribe | 2005-05-13 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
| ➤ Subscribe | Extended-release Capsules | 40 mg | ➤ Subscribe | 2007-03-15 |
International Patents for Lannett Co Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2286815 | ➤ Try a Free Trial |
| Australia | 9701101 | ➤ Try a Free Trial |
| Norway | 20031843 | ➤ Try a Free Trial |
| Cyprus | 1118946 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Lannett Co Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| /1997 | Austria | ➤ Try a Free Trial | PRODUCT NAME: ATORVASTATIN CALCIUM; NAT. REGISTRATION NO/DATE: 1-21926, 1-21927, 1-21928 19970411; FIRST REGISTRATION: GB PL 00018/0240 - PL 00018/0242 19961107 |
| C0021 | Belgium | ➤ Try a Free Trial | PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209 |
| C0030 | France | ➤ Try a Free Trial | PRODUCT NAME: EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 32075 20060623; FIRST REGISTRATION: LI - 55783 01 20020607 |
| 427 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: ARIPIPRAZOLE |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
